KRT20 and colorectal cancer: In comparison, only a fraction of appendiceal and colorectal cancer cases exhibit both markers (22% and 11%, respectively), 78% and 79% of these cases, respectively, are CK7– CK20+, 0% and 3% are CK7+ CK20–, and 0% and 6% are CK7– CK20– (1).